Trial Profile
A Phase I Multiple Ascending Dose Study of BMS-754807 in Subjects With Advanced or Metastatic Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Aug 2013
Price :
$35
*
At a glance
- Drugs BMS 754807 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 13 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jul 2012 Planned number of patients changed from 50 to 63 as reported by ClinicalTrials.gov.
- 03 Jul 2012 Planned end date changed from 1 Jun 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.